NEO
NEOGENOMICS INC
Key Financials
Revenue
$131.2M
N/A
Net Income
$-108025000
↓ 37.2%
Gross Profit
$314.3M
↑ 8.3%
Operating Income
$-115881000
↓ 25.8%
Total Assets
$1.4B
↓ 17.0%
Total Liabilities
$523.3M
↓ 28.9%
Cash & Equivalents
$159.6M
↓ 56.5%
Shareholders' Equity
$836.6M
↓ 7.3%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SCHEDULE 13G/A | 5/15/2026 | View on SEC |
| SCHEDULE 13G/A | 5/13/2026 | View on SEC |
| 4 | 5/13/2026 | View on SEC |
| 4 | 5/13/2026 | View on SEC |
| SCHEDULE 13G/A | 5/7/2026 | View on SEC |
| 4 | 5/5/2026 | View on SEC |
| 4 | 5/5/2026 | View on SEC |
| 4 | 5/5/2026 | View on SEC |
| SCHEDULE 13G | 4/30/2026 | View on SEC |
| SCHEDULE 13G | 4/29/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | NEO |
| Company Name | NEOGENOMICS INC |
| CIK | 1077183 |
| Sector | Services-Testing Laboratories |
| Industry | Large accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 8734 |
| SIC Description | Services-Testing Laboratories |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | NV |
| Phone | 2397680600 |